![]() |
市場調查報告書
商品編碼
1980614
血壓計市場規模、佔有率、成長及全球產業分析:按類型、應用和地區分類,並提供 2026-2034 年的見解和預測Blood Pressure Monitors Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受心血管疾病盛行率上升、測量設備技術進步以及居家醫療模式轉變的推動,全球血壓監測儀市場正經歷強勁成長。預計到2025年,該市場規模將達到21.5億美元,2026年將成長至23.3億美元,到2034年將達到48.3億美元,預測期內複合年成長率(CAGR)為9.5%。北美地區預計在2025年佔據市場主導地位,市佔率高達42.70%。這主要歸功於高血壓的高盛行率、主要市場參與者的強大實力以及先進診斷設備的廣泛普及。
血壓計是測量個人收縮壓和舒張壓的重要工具。這些設備正日益廣泛地應用於高血壓和心律不整等心血管疾病的診斷、監測和管理。根據世界衛生組織(世衛組織)統計,2019年全球約有1,790萬人死於心血管疾病,其中85%是由心臟病發作或中風引起的。除了心血管疾病發生率的上升,新興國家不斷成長的醫療保健成本也推動了全球對血壓計的需求。
新冠疫情期間,由於急診對新冠患者生命徵象監測的需求激增,市場一度受到衝擊。然而,隨著疫情情勢逐漸好轉,市場成長在2021年趨於穩定。疫情期間,OMRON醫療、Hill-Rom Holdings和GE醫療等主要企業因設備使用量增加,銷售額均成長。
市場趨勢
一個重要的趨勢是居家醫療模式。由於高血壓等疾病需要頻繁監測,越來越多的患者開始使用家用血壓監測儀。結合遠端醫療和穿戴式數位設備,可以實現持續監測和數據傳輸,從而提高患者的依從性。例如,Aktiia SA公司於2021年1月推出了一款全天候自動血壓監測系統,即使在睡眠期間也能準確追蹤血壓。
市場促進因素
其主要驅動力是心血管疾病盛行率的上升。根據世界衛生組織2023年的報告,全球30至79歲的成年人中有12.8億人患有高血壓,其中大多數居住在中低收入國家。全球人口老化進一步擴大了高血壓患者群體,尤其是在中國、印度和日本等國家,對監測設備產生了持續的需求。
政府的各項措施和宣傳宣傳活動也正在推動血壓監測的普及。例如,2021年,英國國家醫療服務體系(NHS)強調預防醫學,並向22萬名血壓控制不佳的高血壓患者免費發放了血壓計。作為回應,製造商紛紛推出具備藍牙連接和行動醫療應用程式整合等先進功能的設備。例如,2020年10月,Omron Healthcare在印尼發布了HEM-7361T和HEM-7156兩款血壓計,這兩款產品均具備無線連線功能。
抑制因子
先進設備的高成本以及一些新興地區民眾認知度較低,阻礙了市場成長。 2023年的一項調查發現,在澳大利亞,家庭血壓監測的費用約為每人每年6,400美元,而前往醫療機構監測的費用則為6,700美元。此外,設備檢驗問題也屢見不鮮。 2020年的一項調查發現,在澳洲線上銷售的972台血壓計中,93.4%檢驗,這阻礙了醫療專業人員和患者的使用。
市場區隔
副產品
市場區隔將市場分為設備和配件兩部分。設備部分主要得益於其在臨床和家庭環境中的廣泛應用,預計到2026年將佔據市場主導地位,市佔率高達80.69%。此部分包括血壓計、電子血壓計和攜帶式血壓計。袖帶和感測器等配件的市場成長主要源自於設備的普及和一次性配件需求的增加。
最終用戶
預計到2026年,居家醫療將佔據69.96%的市場佔有率,這反映出患者自我監測的日益普及以及對數位化設備的偏好。醫院和診所領域在醫療基礎設施擴張的推動下穩步成長,而其他領域則透過研發和創新設備的推出呈現溫和成長。
The global blood pressure monitors market is witnessing robust growth driven by the rising prevalence of cardiovascular diseases, technological advancements in monitoring devices, and an increasing shift toward home healthcare. The market was valued at USD 2.15 billion in 2025, projected to grow to USD 2.33 billion in 2026, and is expected to reach USD 4.83 billion by 2034, exhibiting a CAGR of 9.5% during the forecast period. North America dominated the market in 2025 with a 42.70% share, attributed to the high prevalence of hypertension, strong presence of leading market players, and widespread availability of advanced diagnostic devices.
Blood pressure monitors are essential tools for measuring systolic and diastolic blood pressure in individuals. These devices are increasingly adopted for diagnosing, monitoring, and managing cardiovascular disorders such as hypertension and cardiac arrhythmia. According to the World Health Organization (WHO), around 17.9 million people died from cardiovascular diseases globally in 2019, of which 85% were due to heart attacks and strokes. The growing incidence of cardiovascular disorders, along with increasing healthcare expenditure in emerging countries, is fueling the demand for blood pressure monitors worldwide.
The COVID-19 pandemic temporarily affected the market, as demand surged in emergency departments for monitoring COVID-19 patients' vitals. However, as the situation normalized, growth stabilized in 2021. During the pandemic, major players such as Omron Healthcare, Hill-Rom Holdings, and GE Healthcare witnessed revenue growth due to increased device utilization.
Market Trends
A key trend is the shift toward home healthcare settings. With frequent monitoring required for conditions such as hypertension, patients are increasingly adopting home-based blood pressure monitors. Telehealth integration and wearable digital devices allow continuous monitoring and data transfer, improving patient compliance. For example, Aktiia SA launched a 24/7 automated BP monitoring system in January 2021, enabling accurate blood pressure tracking even during sleep.
Market Drivers
The primary driver is the rising prevalence of cardiovascular disorders. In 2023, WHO reported 1.28 billion adults aged 30-79 years worldwide had hypertension, with the majority residing in low- and middle-income countries. The aging global population further increases the patient pool, particularly in countries like China, India, and Japan, creating a sustained demand for monitoring devices.
Government initiatives and awareness campaigns also boost adoption. For instance, in 2021, the NHS in the UK distributed free BP monitors to 220,000 patients with uncontrolled hypertension, emphasizing preventive care. Manufacturers are responding by launching devices with advanced features, such as Bluetooth connectivity and integration with mobile health applications. For example, in October 2020, Omron Healthcare launched HEM-7361T and HEM-7156 with wireless connectivity in Indonesia.
Restraining Factors
High costs of advanced devices and lack of awareness in certain emerging regions hinder market growth. A 2023 study indicated that home BP monitoring in Australia costs around USD 6,400 per year per person, while clinic monitoring costs USD 6,700. Additionally, device validation issues have been reported; a 2020 study found 93.4% of 972 online-sold BP monitors in Australia were non-validated, reducing adoption among healthcare providers and patients.
Market Segmentation
By Product
The market is segmented into devices and accessories. The devices segment dominated with an 80.69% share in 2026, driven by widespread use in clinical and home settings. This segment includes sphygmomanometers, digital BP monitors, and ambulatory BP monitors. Accessories, such as cuffs and transducers, are growing due to increasing device adoption and the demand for disposable components.
By End-User
Home healthcare dominated with 69.96% market share in 2026, reflecting increased patient preference for self-monitoring and digital devices. The hospitals & clinics segment is growing steadily, supported by expanding healthcare infrastructure, while the others segment shows moderate growth through research and innovative device launches.
Key Players and Developments
Leading players include Omron Healthcare (Japan), Hill-Rom Holdings (U.S.), Nihon Kohden (Japan), Koninklijke Philips (Netherlands), Masimo (U.S.), Beurer GmbH (Germany), GE Healthcare (U.S.), American Diagnostic Corporation (Europe), and SunTech Medical (U.S.).
Recent developments:
Conclusion
The blood pressure monitors market is set to grow from USD 2.15 billion in 2025 to USD 4.83 billion by 2034, driven by rising cardiovascular disorders, home healthcare adoption, technological advancements, and government awareness programs. Despite high costs and validation challenges, growing patient awareness and product innovation ensure sustained market expansion.
Segmentation By Product
By End-user
By Region